ライフサイエンスコーパス: there was no difference in

1 Among participants with CAC>0, there was no difference in CAC score (P=0.20), area (P=0.21),

2 r initial shockable rhythms (from 58.9% to 69.2%; P<0.001), there was no difference in unadjusted rate of successful card

3 However, in 2013, there was no difference in the percentage of patients who ini

4 At postoperative days 3 and 30, there was no difference in estimated glomerular filtration ra

5 In addition, there was no difference in mean visual outcome of the first v

6 Additionally, there was no difference in the ability of mu-opioid receptor

7 After propensity score adjustment, there was no difference in the hazard of the primary composit

8 Also, there was no difference in the proportion of wild-type 23 S r

9 Although there was no difference in DFS between anatomical and nonanat

10 Although there was no difference in PGF2alpha levels in PVAT between f

11 Although there was no difference in risk of graft failure across all a

12 In adjusted analyses, there was no difference in long-term survival for right-sided

13 s of follow-up (HR, 0.79 [95% CI, 0.69-0.91]; P=0.001), and there was no difference in in-hospital morbidity.

14 h regard to the prevention of S. pneumoniae bacteremia, and there was no difference in mortality.

15 BC(HIGH) mice did not differ in size or fibrin content, and there was no difference in levels of circulating thrombin-ant

16 tive function was more frequent with WBRT than with SRS and there was no difference in overall survival between the treat

17 Diastereomer pairs entered cells equally well, and there was no difference in intracellular accumulation of L-al

18 For Medicare beneficiaries, there was no difference in geographic access to YAG laser cap

19 Six studies (257 patients) reported rates of any bleeding; there was no difference in the proportions of patients with m

20 ead (95% confidence interval [CI]: -66, -26, P < .001), but there was no difference in sustained reading speeds between g

21 IQR], -61 to -26% vs. -4%; IQR, -14 to +4%; P = 0.003), but there was no difference in TAPSE.

22 sport capacity was also greater in Loda than HS93-4118, but there was no difference in the response of photosynthetic tra

23 compared with wild-type bone marrow-derived mast cells, but there was no difference in degranulation when cells were acti

24 ut task representations in frontal and parietal cortex, but there was no difference in the decoding accuracy of task-rela

25 XB2 from PVAT from females was greater than from males, but there was no difference in the contraction by the TXA2 agonis

26 hen high-flow nasal cannulae were compared with usual care, there was no difference in mortality (high-flow nasal cannula

27 In a propensity score-matched comparison, there was no difference in the primary end point within 12 mo

28 In conclusion, there was no difference in the comparison of AL, ACD and kera

29 In contrast, there was no difference in 24-hour UFC excretion: 6.91 nmol/m

30 After adjusting for covariates, there was no difference in mortality (abusive head trauma, 25

31 By using the Medicare Limited 5% dataset, there was no difference in driving distance between beneficia

32 Despite markedly different inactivation dynamics, there was no difference in AP parameters across a wide range

33 ary blood flow adjusted for differences in patient factors, there was no difference in the primary end point, death or un

34 Pneumonia was uncommon, with no differences between groups; there was no difference in other serious adverse events betwe

35 However, there was no difference in activities of tau kinases and phos

36 However, there was no difference in GA content in tissues between male

37 However, there was no difference in nonfatal stroke, cardiovascular di

38 Before program launch, there was no difference in mortality trends between the compl

39 After adjustment for age and educational level, there was no difference in the postoperative cognitive perfor

40 Likewise, there was no difference in wound complication rate between pa

41 for perinatal characteristics and preligation morbidities, there was no difference in the odds of death or NDI (adjusted

42 After adjustment for covariates (including surgery), there was no difference in all-cause mortality between Vmax 4

43 Among the 767 patients without trauma, there was no difference in the adjusted odds ratio (aOR) for

44 In EGFR FISH-negative tumors, there was no difference in overall survival with gefitinib co

45 size of tumors was significantly larger in WT mice, whereas there was no difference in the number of alveolar lesions bet

46 -1beta compared with BMDCs treated with free oxLDL, whereas there was no difference in levels of TNF-alpha or IL-6.

47 igher absolute forces at low isokinetic velocities, whereas there was no difference in force at the highest velocities.

48 patients with BVS was higher between 1 and 2 years, whereas there was no difference in the first year.

49 While there was no difference in the total amounts of phospholipids

50 there was no delay between stop and change stimulus, while there was no difference in the 300 ms delay condition.